Imeik Technology Development Co.,Ltd. (SHE:300896)
138.72
-1.94 (-1.38%)
Mar 9, 2026, 3:04 PM CST
SHE:300896 Revenue
Imeik Technology Development had revenue of 565.78M CNY in the quarter ending September 30, 2025, a decrease of -21.27%. This brings the company's revenue in the last twelve months to 2.52B, down -18.20% year-over-year. In the year 2024, Imeik Technology Development had annual revenue of 3.03B with 5.45% growth.
Revenue (ttm)
2.52B
Revenue Growth
-18.20%
P/S Ratio
16.63
Revenue / Employee
2.06M
Employees
1,223
Market Cap
41.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.03B | 156.32M | 5.45% |
| Dec 31, 2023 | 2.87B | 930.51M | 47.99% |
| Jan 1, 2023 | 1.94B | 490.97M | 33.91% |
| Jan 1, 2022 | 1.45B | 738.58M | 104.13% |
| Dec 31, 2020 | 709.29M | 151.57M | 27.18% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gan & Lee Pharmaceuticals. | 3.85B |
| Intco Medical Technology | 9.85B |
| iRay Group | 2.30B |
| Zhende Medical | 4.32B |
| Andon Health | 1.57B |
| Winner Medical | 10.80B |
| Shenyang Xingqi Pharmaceutical | 2.41B |
| Jiangsu Hualan New Pharmaceutical Material | 604.86M |